Clinical Safety

As a biopharma expert with a deep background in research and technology, Ivan Kairatov has a unique perspective on the intersection of artificial intelligence and frontline medicine. His work focuses on how innovations like causal modeling can translate complex data into life-saving actions. Today,

The single greatest risk factor for developing Parkinson's disease has been systematically overlooked in the very laboratories dedicated to finding a cure, a baffling disconnect that a global consortium of scientists is now moving urgently to correct. For decades, the relentless march toward

The landscape of hematology is undergoing a significant transformation, driven by a new consensus that seeks to correct decades of suboptimal outcomes for a frequently overlooked demographic caught between two distinct worlds of medical care. For years, adolescents and young adults (AYAs) diagnosed

Today, we're joined by Ivan Kairatov, a biopharma expert with deep knowledge of technological innovation in research and development. We'll be diving into the groundbreaking 20-year findings from the ACTIVE study, which suggest a specific type of cognitive training could significantly reduce the

The quiet confidence that comes with taking a daily pill to manage cholesterol or blood pressure often masks a dangerous misconception that its protective shield is impenetrable, regardless of what one eats. This belief, however, is being challenged by rigorous scientific inquiry, forcing a

An experimental oral medication for obesity has delivered substantial weight loss in a mid-stage trial, heralding the arrival of a formidable new challenger in a market dominated by pharmaceutical titans. Co-developed by Hengrui Pharma and Kailera Therapeutics, the pill, known as ribupatide,